SCHEMBL25005574

SCHEMBL25005574

CC(C)CNC(=O)c1cccc(NC(=O)c2ccc([N+](=O)[O-])o2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 2/20 0.64
▸ KMT2A Q03164 7/20 0.62
▸ LMNA P02545 6/20 0.62
▸ MEN1 O00255 6/20 0.62
▸ GAA P10253 5/20 0.62
▸ MAPT P10636 4/20 0.62
▸ MAPK1 P28482 2/20 0.62
▸ PAX8 Q06710 3/20 0.58
▸ HTT P42858 2/20 0.56
▸ KDM4E B2RXH2 1/20 0.56
▸ RAB9A P51151 1/20 0.56
▸ MITF O75030 2/20 0.55
▸ NPC1 O15118 1/20 0.55
▸ NFKB1 P19838 1/20 0.55
▸ NFKB2 Q00653 1/20 0.55
▸ RELA Q04206 1/20 0.55
▸ HSD17B10 Q99714 1/20 0.52
▸ STING1 Q86WV6 1/20 0.51
▸ POLB P06746 2/20 0.51
▸ RAC1 P63000 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25005417 0.88 JAK2 (0.67) JAK2KMT2ALMNAMEN1GAA
SCHEMBL22804226 0.86 JAK2 (0.67) JAK2KMT2ALMNAMEN1GAA
SCHEMBL24291456 0.85 LMNA (0.71) JAK2KMT2ALMNAMEN1GAA
SCHEMBL22822605 0.84 JAK2 (0.72) JAK2KMT2ALMNAMEN1GAA
SCHEMBL29462179 0.84 JAK2 (0.72) JAK2KMT2ALMNAMEN1GAA
SCHEMBL22804228 0.84 JAK2 (0.75) JAK2KMT2ALMNAMEN1GAA
SCHEMBL25006066 0.83 JAK2 (0.61) JAK2KMT2ALMNAMEN1GAA
SCHEMBL22822784 0.81 JAK2 (0.58) JAK2KMT2ALMNAMEN1GAA
SCHEMBL22822771 0.81 JAK2 (0.70) JAK2KMT2ALMNAMEN1GAA
SCHEMBL22804227 0.80 JAK2 (0.69) JAK2KMT2ALMNAMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112107568-B Diaryl amide compound and application thereof 北京龙嘉博创医药科技有限公司 2022-03-25 — — CN claimed
CN-112107568-A Diaryl amide compound and application thereof 北京大学 2020-12-22 — — CN claimed
US-20230045031-A1 Diarylamide Compound and Application Thereof SUNSHINE LAKE PHARMA CO., LTD. (CN) 2023-02-09 — — US disclosed
CN-112107568-B Diaryl amide compound and application thereof 北京龙嘉博创医药科技有限公司 2022-03-25 — — CN disclosed
CN-112107568-A Diaryl amide compound and application thereof 北京大学 2020-12-22 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230045031-A1 Diarylamide Compound and Application Thereof SLC14A1, SLC28A1, SLC28A2 JAK2 3981/4885KMT2A 3036/4885LMNA 3332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback